VEGFA and neoplasm: This is in part due to the upregulation of alternative pro-angiogenic growth factors within the tumor to overcome VEGF blockade (Bergers and Hanahan, 2008; Ellis and Hicklin, 2008; Carmeliet and Jain, 2011; Jayson et al., 2016; Fukumura et al., 2018).